BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK

HONG KONG, Jan 17, 2023 - (ACN Newswire via SEAPRWire.com) - Beauty Farm Medical and Health Industry Inc. ("BeautyFarm Med" or "Company", stock code: 2373.HK), the largest provider of traditional beauty services in China in term of revenue in 2021, successfully listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today, with a board lots of 500 shares each. The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price. The share price closed at HK$29.65, up 53.5% and represents a market capitalization of HK$ 6.83billion.Morgan Stanley Asia Limited, Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited are the Joint Sponsors to the global offering; Morgan Stanley Asia Limited, Haitong International Securities Company Limited and Huatai Financial Holdings (Hong Kong) Limited are the Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Managers to the global offering.The Company states that the listing of BeautyFarm Med in Hong Kong marks a key milestone and unfolds a new chapter in the Company's development. Looking ahead, BeautyFarm Med will strategically expand its service network and marketing channels to enlarge its client base and increase brand awareness. The Company will also further enhance its operational efficiency and client experience by introducing new technologies, equipment and products, and expanding its service offerings. Moreover, the Company will continue to cultivate, recruit and retain high-caliber talent and strengthen its human resources management mechanism; and integrate industry resources and promote the development of industry standards by deepening cooperation with upstream suppliers and sharing its industry and management experience, thereby creating greater value for the clients, shareholders and employees. Beauty Farm Medical and Health Industry Inc.Beauty Farm Medical and Health Industry Inc. (stock code: 2373.HK) is a leading player in China's beauty and health management service industry, which has a large and loyal client base, extensive network with expansion efficiency, diversified services and product offerings as well as strong brand awareness. BeautyFarm Med is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6%, respectively, as measured by revenue in 2021 and according to Frost & Sullivan. The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology. The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle. This press release is issued by Porda Havas International Finance Communications Group for and on behalf of Beauty Farm Medical and Health Industry Inc. For further information, please contact: Porda Havas International Finance Communications GroupTel: 852 3150 6788Email: projectgarden.hk@pordahavas.com Copyright 2023 ACN Newswire. All rights reserved. (via SEAPRWire)
More

BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

HONG KONG, Jan 13, 2023 - (ACN Newswire via SEAPRWire.com) - Beauty Farm Medical and Health Industry Inc. ("BeautyFarm Med" or "Company", stock code: 2373.HK), the largest provider of traditional beauty services in China, today announced the allotment results of its Global Offering. The Offer Price is HK$19.32 per share. Dealings in the shares of the Company on the Main Board of the Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") are expected to commence on 16 January 2023 (Monday) with a board lot size of 500 shares.The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been very significantly oversubscribed. A total of 6,671 valid applications have been received under the Hong Kong Public Offering through the White Form eIPO service and the CCASS EIPO service for a total of 89,670,000 Hong Kong Offer Shares, representing approximately 22.12 times of the total number of 4,054,000 Hong Kong Offer Shares initially available for subscription under the Hong Kong Public Offering. The Offer Shares initially offered under the International Offering have been moderately oversubscribed, representing approximately 4.7 times of the total number of 36,482,500 International Offer Shares initially available for subscription under the International Offering. The proceeds raised from the Global Offering of shares received by the Company are planned to be used to expand and upgrade the service network, carry out strategic mergers and acquisitions of franchise stores, and further invest in IT systems. The Company stated, through nearly three decades of deep cultivation in the industry and integration of resources, BeautyFarm Med has become a leading player in China's beauty and health management service industry. The official listing on the Hong Kong Stock Exchange marks an important milestone in the history of the development of BeautyFarm Med, opening a new chapter for the Company's development. The outstanding share oversubscription shows the trust and support of global investors for the Company's business development and lays a firm ground for the Company's long-term growth. Looking forward, BeautyFarm Med will continue strategically expanding its service network and marketing channels, introducing new technologies, equipment and products, and expanding its service offerings; continuing to cultivate, recruit and retain high-caliber talent; and integrating industry resources by deepening cooperation with upstream suppliers, thereby continuing to create greater value for the clients, shareholders and employees.Beauty Farm Medical and Health Industry Inc.Beauty Farm Medical and Health Industry Inc. (stock code: 2373.HK) is a leading player in China's beauty and health management service industry, which has a large and loyal client base, extensive network with expansion efficiency, diversified services and product offerings as well as strong brand awareness. BeautyFarm Med is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6%, respectively, as measured by revenue in 2021 and according to Frost & Sullivan. The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology. The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle. This press release is issued by Porda Havas International Finance Communications Group for and on behalf of Beauty Farm Medical and Health Industry Inc. For further information, please contact: Porda Havas International Finance Communications GroupTelephone: 852 3150 6788Email: projectgarden.hk@pordahavas.com Copyright 2023 ACN Newswire. All rights reserved. (via SEAPRWire)
More
China Box, a Completely New Watch-to-Earn NFTs Project Is Officially Launched SeaPRwire

China Box, a Completely New Watch-to-Earn NFTs Project Is Officially Launched

A non-profit project with the ultimate goal of becoming the largest digital gallery to showcase all amazing aspects of China, the country with the longest continuous history in the world New York, NY, January 04, 2023 – (SEAPRWire) – NFTs have taken over the internet. No one, from businesses to brands and celebrities, can deny onboarding the NFT bandwagon. Unlike any new NFT projects that are spawned into the market every other day, China Box chooses a completely different approach as it is dedicated to honor Chinese culture and aim to become the largest digital gallery to showcase all amazing aspects of the country with the longest continuous history in the world. China Box positions itself as a videoverse where users can watch spectacular Chinese stories and collect randomly dropped virtual items along the way. The rule of the game is very simple, like other watch-to-earn projects, the more time users spend enjoying the provided videos, the more chance they will have to receive free and exclusively designed NFTs. Product Manager of China Box excitedly commented on the launch: “As we enter a new digital era powered by blockchain, China Box sees our mission of utilizing this modern technology not only to introduce all the wonderful and amazing aspects of China to the world but also to truly incentivize people to deep dive into the stories about the country’s history, traditions and customs, latest developments, and promising future. This is the core value of our project, and it is also the key competitive advantage of China Box in the sea of watch-to-earn and NFT projects out there.“ China Box aims to give users the best experiences in their journey to explore the beauty of China. With a very user-friendly interface and easy-to-understand features, China Box’s current videoverse includes five key sections to deliver a comprehensive picture of the country: Cuisine (“Taste of China”), Technology Development (“Technology”), People (“1.4 billion”), Traditional Martial Arts (“Kung Fu”) and of course, Landscape (“Nature”). Each section consists of dozens of short-to-medium-length jaw-dropping videos which have been carefully selected. Transforming into a customizable panda warrior, users will have the chance to explore all these sections, and completely immerse into a magical Chinese-inspired virtual world. “We treat each user as a valuable ambassador of not only the project itself but also the beauty of China. Therefore, in the upcoming months, to maximize users’ experience and build a strong loyal community, China Box will keep delivering more informative videos at the highest quality; at the same time, more unique NFTs that you cannot find anywhere else will also be introduced.” Product Manager said. In 2023, besides enriching its videoverse, China Box also has a clear roadmap of introducing new features allowing users to mint NFTs, as well as NFT airdrops. China Box is another typical example of the integration between technology, artistic and cultural heritage, where blockchain and its application can play a vital role in promoting local cultural prosperity and economic development. Visit https://www.videostory.com/chinabox/ to take a look at this Chinese-inspired virtual world. Keep an eye on China Box’s twitter account to get all the latest updates: https://twitter.com/ChinaBox2022 Media Contact Brand: China Box Contact: Media team Website: https://www.videostory.com/chinabox/ SOURCE: China Box The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More

Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share

HONG KONG, Dec 30, 2022 - (ACN Newswire via SEAPRWire.com) - Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or "Company", stock code: 2373), the largest provider of traditional beauty services in China, today announces the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK").Beauty Farm plans to offer an aggregate of 40,536,500 Offer Shares under the Global Offering (subject to the Over-allotment Option), consisting of 36,482,500 International Offer Shares (subject to reallocation and the Over-allotment Option) and 4,054,000 Hong Kong Offer Shares (subject to reallocation), at a price of HK$19.32 per share.The Company will start its public offering in Hong Kong at 9 a.m. on 30 December, 2022 (Friday) and end at 12 noon on 6 January, 2023 (Friday). Dealings in shares on SEHK are expected to commence on 16 January 2023 (Monday), with the stock code of 2373 in board lots of 500 shares each.Morgan Stanley Asia Limited, Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited are the Joint Sponsors; Morgan Stanley Asia Limited, Haitong International Securities Company Limited and Huatai Financial Holdings (Hong Kong) Limited are the Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Managers.Beauty and health management service provider with diversified brand portfolio in ChinaBeauty Farm is a leading player of the chain service brand in China's beauty and health management service industry, which has large and loyal client base, extensive network with expansion efficiency, diversified services and product offerings as well as strong brand awareness. According to Frost & Sullivan, Beauty Farm is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6% respectively, as measured by revenue in 2021. The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology. The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle. As of June 30, 2022, the overall service network of Beauty Farm comprised 352 stores, including 177 direct stores and 175 franchised stores. Among the direct stores, 84 stores were located in tier-one cities and 73 stores were located in new tier-one cities.Constant evolution of business model in response to market demand, offering clients overall beauty and health management servicesAs the leading chain brand in China's beauty and health management service industry, Beauty Farm has provided traditional beauty services to clients for nearly three decades. With insights into clients' increasingly diversified demand accumulated through years of services, the Company has extended its offerings by providing more sophisticated services such as aesthetic medical services since 2011. Thereafter, the Company commenced to build its subhealth assessment and intervention service capacity in 2018, in response to the rising demand of subhealth assessment and intervention services as a result of consumption upgrade and China's rising prevalence rate of subhealth status. Counting the revenue generated in 2021, traditional beauty services, aesthetic medical services, and subhealth assessment and intervention services represented 58.8%, 37.8% and 3.4% of the total revenue for the year. These service offerings of Beauty Farm complement each other and create a synergistic effect for the overall operations of the Company. The Company's long history in traditional beauty services has positioned the Company uniquely in the industry and fueled the revenue growth without significant increase in customer acquisition costs as the Company has become many members' lifelong trusted advisor on health and beauty. And 21.7% and 21.2% of members of the Company's traditional beauty services in 2021 and the six months ended June 30, 2022, respectively, purchased aesthetic medical services or subhealth assessment and intervention services, which is expected to further grow in the future. Likewise, the expansion of aesthetic medical services and subhealth assessment and intervention services can also further boost the growth of traditional beauty services going forward.Standardized services supported by digitalized platformBeauty Farm has established an integrated service platform to ensure high-quality services to its clients in a consistent manner across all stores. The digitalized platform of the Company is supported by standardized operating procedures and digital infrastructure covering stringent quality control, training system and supply chain management. The Company achieved one of the few highest service personnel annual retention rates in 2021 within the beauty and health management service industry. Among all the service personnel who have stayed with us for more than one year, they have an average of 6.1 years of retention. The standardization and digitalization of the business platform provides scale advantages across various aspects of the Company's operations that can be leveraged by its stores and service personnel. The integrated service platform is capable of consolidating and processing operational data accumulated from various systems across the store network. The Company also applies data mining and data analytics to obtain valuable insights to profile its clients' transaction patterns, consumption habits, and lifetime client value. Such tech-enabled enhancements allow the Company to customize its services according to clients' needs so as to maintain their stickiness and identify cross-selling opportunities. The platform-based operating model allows Beauty Farm to standardize various aspects of its operations to improve both client experience and the service performance of its service personnel. In addition, as the Company continues to accumulate and analyze digital information from its day-to-day business operations, the Company can further improve its operational efficiency.A large client base of active members supported by CRM systemThe comprehensive service offerings of Beauty Farm have attracted a large base of active clients, which is supported by a comprehensive client service system. In 2021, the direct stores of the Company served 77,356 active members, which was increased by 12.5% in 2020. The active members from direct stores on average made 10.8 visits (2020: 10.2 visits) and spent RMB20,832 in 2021 (2020: RMB20,151). 80.7%, 82.1%, 84.6% and 77.0% of the active members in 2019, 2020, 2021 and the six months ended June 30, 2022 made multiple purchases of the Company's services in the same period, respectively. In addition to the increasing client volume in direct stores, the franchised stores of the Company served 27,916 active members in 2021 and 22,552 active members in the six months ended June 30, 2022. Sustainable development supported by organic growth and strategic acquisitionsBeauty Farm has a proven track record of rapidly expanding its geographic footprint across China and has achieved rapid and sustainable business growth through both organic growth and strategic acquisitions. The scalability and replicability of its business is evidenced by its ability to open new stores rapidly. The Company opened 45 new direct stores from 2019 to June 30, 2022. Beauty Farm is able to ramp-up its new stores and achieve profitability efficiently. Contributed by the Company's long-term business relationship with prime shopping malls and the ability to bring strong footage to the venue, the typical lead time from the completion of site selection to store opening is approximately three months. From 2014 to June 30, 2022, a new traditional beauty service store on average achieved initial breakeven in eleven months after commencement of operation.Beauty Farm experienced a successful track record of identifying, acquiring and integrating stores into its network. The Company has completed 20 acquisitions in beauty and health management service industry from 2014 to June 30, 2022, most of which have successfully enhanced the Company's business offerings and management team. Upon the completion of integration, acquired stores typically witness improved business performance and rapid client expansion. For example, the acquisition of Palaispa shows the Company's acquisition power and capabilities in integration. Revenue generated from Palaispa members and franchisees increased from RMB102.4 million in 2017 to RMB185.7 million in 2021 at a CAGR of 16.0%. Those acquired stores were smoothly integrated into the Company's network, ensuring further synergies and value creation. Going forward, Beauty Farm will continue to identify and evaluate acquisition opportunities in high-quality stores to capture growth opportunities.The success of Beauty Farm is also attributable to its visionary and dedicated management with extensive industry experience, as well as strong shareholder support. Since 2013, CITIC PE, who has extensive experience managing and growing companies in the beauty and health management service industry, has been working closely with Beauty Farm to establish a standardized and disciplined chain business with nationwide footprint and has made important contributions to the company's strategic formulation, merger and expansion, executive recruitment, brand and design, human resources, supply chain, marketing, finance and other aspects of management improvement.Looking forward, Beauty Farm plans to carry out below key growth strategies to realize its development, including strategically expanding its service network and marketing channels to expand its client base and increase brand awareness; further enhancing its operational efficiency and client experience through standardization and digitalization of its system; improving client loyalty and fulfilling clients' evolving needs by introducing new technologies, equipment and products, and expanding its service offerings; continuing to cultivate, recruit and retain high-caliber talent and strengthen its human resources management mechanism; and integrating industry resources and promoting the development of industry standards by deepening cooperation with upstream suppliers and sharing its industry and management experience.Beauty Farm Medical and Health Industry Inc.Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or "Company", stock code: 2373) is a leading player in China's beauty and health management service industry, which has large and loyal client base, extensive network with expansion efficiency, diversified services and product offerings as well as strong brand awareness. According to Frost & Sullivan, Beauty Farm is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6% respectively, as measured by revenue in 2021. Leveraging 29 years of industry experience and adapting to evolving client demand, the Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology. The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle. This press release is issued by Porda Havas International Finance Communications Group for and on behalf of Beauty Farm Medical and Health Industry Inc. For further information, please contact: Porda Havas International Finance Communications GroupTelephone: 852 3150 6788Email: projectgarden.hk@pordahavas.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
L’Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners, launches SHIHYO, a newly created luxury beauty brand ACN Newswire

L’Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners, launches SHIHYO, a newly created luxury beauty brand

SHANGHAI, Nov 21, 2022 - (ACN Newswire via SEAPRWire.com) - L'Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners, is launching a newly created luxury beauty brand 'SHIHYO' through Loshian, a third-party joint venture. This is the first time L'Oreal is launching a new beauty brand through a joint venture."SHIHYO" is a new luxury beauty brand launched by L'Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners through a joint venture LoshianSHIHYO, which means "the wisdom of time," is a newly created skincare beauty brand inspired by the Asian wisdom of the 24 seasons. SHIHYO embodies the healthy energy of nature, powered by herbal sciences.The new brand is based on the naturality of 24 herbal ingredients harvested at the peak of each season, combined with proven efficacy based on scientific research and innovation. All formulas include the signature ingredient called ShiHyo24, a patented, nutrient-rich concentrate of the 24 herbal ingredients infused with fermented rice water and ginseng water.SHIHYO offers 24 different types of ampoules featuring 24 herbal ingredients, along with other skincare products such as facial cleanser, essence, and cream, as well as scalp care products such as shampoo and conditioner.SHIHYO leverages L'Oreal's longstanding beauty expertise, Hotel Shilla's luxury retail channels, and Anchor's robust financial business model. SHIHYO's 1st flagship store, the "Seoul Garden," will open in the coming months at The Shilla Seoul Hotel in Korea, with the ambition of engaging with consumers and offering an immersive experience with an extensive luxury beauty product range.Cyril Chapuy, President of L'Oreal Luxe, said, "L'Oreal LUXE is very pleased to announce the launch of SHIHYO through a partnership with Hotel Shilla and Anchor Equity Partners. Rooted in an exceptional traditional wisdom and knowledge of naturality, SHIHYO represents the epitome of Asian luxury beauty. Empowered by science, SHIHYO delivers the highest skincare quality thanks to its signature patented ingredient, offering the most elevated luxury beauty experience."In-Gyu Han, COO of Hotel Shilla, said, "SHIHYO is a luxury beauty brand that brings out the best of naturality and efficacy with seasonal ingredients directly sourced from local farmers in Korea. With our rich retail expertise married with L'Oreal's strong brand building capabilities, we believe SHIHYO will elevate the desire for natural, luxury beauty in Asia."Sanggyun Ahn, Managing Partner of Anchor Equity Partners, said, "We are glad to join this partnership to support the growth of the most unique brand in Asia and globally. We have full confidence that SHIHYO will meet the discerning consumers' needs with new luxury beauty routines."About L'Oreal GroupeFor over 110 years, L'Oreal, the world's leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 35 international brands and ambitious sustainability commitments in our 'L'Oreal for the Future' programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.With 85,400 committed employees, a balanced geographical footprint and sales across all distribution networks (e-commerce, mass market, department stores, pharmacies, hair salons, branded and travel retail), in 2021 the Group generated sales amounting to 32.28 billion euros. With 20 research centers across 11 countries around the world and a dedicated Research and Innovation team of over 4,000 scientists and 3,000 tech professionals, L'Oreal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse. More information on https://www.loreal.com/en/mediaroomAbout L'Oreal North Asia ZoneL'Oreal North Asia Zone was established in 2021 as L'Oreal Groupe regrouped the geographical scope of its zones to give greater coherence to consumer behaviour and to create synergy within the region. The North Asia Zone comprises of five geographically and culturally connected markets of Mainland China, Hong Kong, Taiwan, Japan and South Korea.L'Oreal North Asia Zone is the second largest region within the Group, accounting for 30.5% of the Group's global sales in 2021. Situated in the most beauty intense region with more than one-third of the world's total beauty consumers, L'Oreal North Asia shapes the future of beauty with its innovation centers in Shanghai, Tokyo and Seoul, while investing in beauty tech transformation as one of the three beauty tech hubs globally. Here, our mission is to strategize, create and activate a powerful ecosystem around the North Asia Beauty Triangle as a competitive edge to unleash sustainable growth for all and inspire the world.Media contact:Linda YAN / linda.yan@loreal.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
The Executive Talk by ShareInvestor: Rojukiss International PCL (SET: KISS) ACN Newswire

The Executive Talk by ShareInvestor: Rojukiss International PCL (SET: KISS)

BANGKOK, Nov 4, 2022 - (ACN Newswire via SEAPRWire.com) - Rojukiss International PCL (SET: KISS) Chief Executive Officer, Ms. Worrawan Chaikamnerd provided an admirable interview regarding her business strategy under the tough timing caused by the Covid-19 pandemic and the company's core vision reflecting future growth.Rojukiss International PCL Chief Executive Officer, Ms. Worrawan Chaikamnerd1. Amid the Covid-19 pandemic, what challenges have your business faced? And what is your key strategy?The COVID-19 pandemic has been one of the major challenges for Thailand's beauty industry and our company. We must refine our strategies and business plans to cope with the ever-changing market and rapidly changing consumer behavior.Regarding the long-term strategy, we aim to increase our top line to 3,000 million baht by 2026. Our focus remains on beauty and health products, such as skincare, makeup, hair color, and food supplements, which align with the company's vision and mission: To be Asia's leading beauty and health company by creating the best innovation to fulfil everyone's demand and inspiring people across Thailand and Asia.2. How is your product development and business expansion plan?The priority is to grow and strengthen our core brand - the Rojukiss brand by enhancing the product innovation. At the same time, we continue searching for opportunities to reach consumers by adjusting marketing strategies called "Beauty Convenience." Since Q1/2022, we have been trying to communicate with consumers through digital channels and leveraging data to create effective communication. All supports from our market research team provides in-depth market insights, ensuring that we proceed with the best fit consumer-based strategy.One tactical approach we used during the pandemic was increasing product volume but maintaining the price. With this promotion, we not only added value and increased customers' access to the product but also captured profitability at a reasonable level. As a result, Rojukiss has continued to grow despite the challenging business environment amid the slow trending of Covid-19 pandemic. with a sales target of 1,000 million baht by 2024 as Rojukiss remains our powerhouse brand.In addition, we have also attempted to push other potential brands, especially "Best Korea" brand, in which we have upgraded into new formulas and imported ingredients from abroad. The brand highlights its 'convenience to carry and use anywhere' concept because we distribute it as a sachet, which also comes up with an affordable price for everyone. Furthermore, we also launched a new product under the Best Korea umbrella, "Best Korea SSUK," targeting to teen shoppers. The company is committed to build Best Korea the Second Pillar.Strengthen the company with health innovationsOur core vision and mission is to become Asia's leading beauty and health company by creating the best health-related innovation. Recently, we invested in Hibiocy Co., Ltd. (HIB) to expand our business into health innovations. Consequently, we were able to roll out the first product called "Vaill CoviTRAP Anti-CoV Nasal Spray", designed to suppress the COVID-19 virus physically. We received a very positive support from the market.Expanding markets and opportunities to become Asia's leading beauty and health companyRegarding the company's long-term plan, we also search for new growth opportunities abroad. Currently, we have entered into four major countries: Indonesia and Vietnam - through the foreign distributor model, Laos and Cambodia - through the cross-broader sale model. In these markets, we found high demand for beauty and health products and similar customer behavior to that of Thai consumers. Particularly in Indonesia, after the product kicked-off, we received an impressive receptivity that exceeded our expectations.Overall, our key strategy is to focus on developing new products, bringing out the best of Rojukiss and adjusting the products to fill the gap in consumption trends. Therefore, we must understand the consumer first, build innovative product, and find a suitable partner whose expertise could bring us into the market.3. At the end of Q3/2022, KISS launched a new product concerning COVID-19 virus prevention. Please tell us about its specialty.For this project, we collaborated with Faculty of Medicine at Chulalongkorn University, the Institute of Health Systems Research (HSRI), Silpakorn University, and the Government Pharmaceutical Organization (GPO) to form up the Thai medical working team to fight against COVID-19. Consequently, we successfully invented Thailand and the world's first innovation in developing a nasal spray with Monoclonal Human Antibody Cocktail technology from research on human immunity to combat and inhibit the COVID-19 virus. It is considered an advanced biological technology developed from decoding antibodies obtained from volunteers who have recovered from COVID-19 infection and have excellent immunity, which helps inhibit and prevent COVID-19 physically. Impressively, it could hinder the infection covering up to 98% of all species and last up to 6 hours.This nasal spray works in two functions; (1) trapping the virus with the HPMC that covers the surface of the nasal cavity, which reduces the virus's ability to embed itself in the nasal cavity, and (2) excellent immunity, adopted from recovered patients (Human Monoclonal Antibodies), will inhibit and block COVID-19 entering the nasal cavity physically.For me, this product is the pride of Thais whose breakthrough innovation could transform society. It shows our indubitable potential, which is second to none in the world.4. What core value have you and your company employees adhered to?As a beauty and health company, we have always committed to integrity, especially to our customers, partners, shareholders, and other stakeholders.Honesty and integrity mean providing valuable products that serve consumers' demands at an accessible price, as well as maintaining consistent Rojukiss grade quality.On behalf of Rojukiss International Pcl, we will continue to develop products through innovations and with latest technologies under ethical business practices and good corporate governance. All aim to orchestrate the organization to grow sustainably.Watch Executive Talk by ShareInvestor on YouTube ShareInvestor Thailand https://www.youtube.com/c/ShareInvestorThailand About The Executive Q&A SeriesThe Executive Q&A Series is presented by ShareInvestor, Asia's leading financial internet media and technology company and the largest investor relations network in the region. For more information, email admin.th@shareinvestor.com, and visit our Website: www.ShareInvestorThailand.com. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More